About: Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific journal article

Attributes	Values
rdf:type	Item
description	artikull shkencor (sq) wetenschappelijk artikel (nl) article scientifique publié en 2005 (fr) artículu científicu espublizáu en 2005 (ast) 2005 թուականի Յունուարին հրատարակուած գիտական յօդուած (hyw) 2005 թվականի հունվարին հրատարակված գիտական հոդված (hy) наукова стаття, опублікована в січні 2005 (uk) مقالة علمية (نشرت عام 2005) (ar) im Januar 2005 veröffentlichter wissenschaftlicher Artikel (de) scientific journal article (en)
publication date	wds:Q28568955-156B5850-4351-4161-AB32-5BBEC099BE79
publication date	2005-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28568955-5C9CCE3C-2BE2-4191-8362-7FBAB0F1C92F
language of work or name	English
author name string	wds:Q28568955-01E3D5A7-7957-42A8-AA22-23662659669E wds:Q28568955-187DCD81-ABF0-46F0-8D4E-DAC9397BD8DB wds:Q28568955-7FDE9A68-73C1-4953-9306-11C4608893C3 wds:Q28568955-CB0281CF-1C72-4290-A230-1B842E761269
author name string	Raimund Hirschberg Shinong Wang Edward B. Leof Mark C. Wilkes
rdfs:label	Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo (en) Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo (nl) Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo (ast)
skos:prefLabel	Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo (en) Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo (nl) Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo (ast)
name	Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo (en) Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo (nl) Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo (ast)
title	wds:Q28568955-27D85F0D-6996-4ED4-872F-95A62BC1AF36
title	Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo (en)
page(s)	wds:Q28568955-EA67BCC1-48CF-4C1C-BE84-92B427397676
page(s)	1–11
instance of	wds:Q28568955-1EEF326E-5060-46F4-83DE-49C65D0626FC
instance of	scholarly article
main subject	wds:Q28568955-D4501435-F558-400F-9C2E-7E0488AC334E
main subject	wd:Q177094
PubMed ID	wds:Q28568955-54EC66FA-8E6F-46CE-8D36-E88D1FE8A230
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15629889
PubMed ID	15629889
published in	wds:Q28568955-54ACA8ED-AAC2-4DBF-BA6B-767A010A728D
published in	FASEB Journal
issue	wds:Q28568955-B1CBEE4D-A856-43CC-9533-D45645BE58F1
volume	wds:Q28568955-4E34697E-279A-4CEF-A072-E6DDDDF31EFF
issue	1
volume	19
DOI	wds:Q28568955-CB583974-504F-4C81-B374-9B8D6FC4DA35
DOI	http://dx.doi.org/10.1096/FJ.04-2370COM
DOI	10.1096/FJ.04-2370COM
ResearchGate publication ID	wds:Q28568955-A446F4F0-D9CE-4BEB-B8B0-CF9C1FC6FF95
ResearchGate publication ID	8100905
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q28568955
is cites work of	Non-Smad pathways in TGF-beta signaling The immune system and cardiac repair. MPP(+)-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress Sphingosine 1-phosphate in coagulation and inflammation. Not on the menu: autophagy-independent clearance of prions Investigational drugs targeting cardiac fibrosis Transforming growth factor beta1-mediated activation of the smooth muscle alpha-actin gene in human pulmonary myofibroblasts is inhibited by tumor necrosis factor-alpha via mitogen-activated protein kinase kinase 1-dependent induction of the Egr-1 t G protein-coupled receptors as therapeutic targets for multiple sclerosis TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis Adenosine 2A receptor promotes collagen production by human fibroblasts via pathways involving cyclic AMP and AKT but independent of Smad2/3. Brain response to calorie restriction Galectin-3 regulates myofibroblast activation and hepatic fibrosis Recent advances in quantitative neuroproteomics Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis. Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: an insight. Noncanonical TGF-beta pathways, mTORC1 and Abl, in renal interstitial fibrogenesis Metabolic links between diabetes and Alzheimer's disease. Transforming growth factor (TGF)-β signaling in cardiac remodeling. Discovery, design and synthesis of novel potent and selective sphingosine-1-phosphate 4 receptor (S1P₄-R) agonists Involvement of oxidative stress in Alzheimer disease Platelet-derived serotonin links vascular disease and tissue fibrosis Targeting fibrosis in Duchenne muscular dystrophy Regulation of α-secretase ADAM10 expression and activity Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling Galvanotactic migration of EA.Hy926 endothelial cells in a novel designed electric field bioreactor Sleep disturbances in Alzheimer's and Parkinson's diseases Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. The role of endothelial cells in inflamed adipose tissue. Mechanisms of the epithelial-mesenchymal transition by TGF-beta Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis. Transforming growth factor beta as a therapeutic target in systemic sclerosis CD90+ mesothelial-like cells in peritoneal fluid promote peritoneal metastasis by forming a tumor permissive microenvironment TGF-β signaling in fibrosis Non-invasive measurement of bioelectric currents with a vibrating probe. Effects of electromagnetic fields on cells: physiological and therapeutical approaches and molecular mechanisms of interaction. A review The role of TGF-beta signaling in myocardial infarction and cardiac remodeling The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages Transforming growth factor-β1 in plaque morphea Obesity-induced inflammation: a metabolic dialogue in the language of inflammation Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258 Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease. Albumin-induced epithelial-mesenchymal transition and ER stress are regulated through a common ROS-c-Src kinase-mTOR pathway: effect of imatinib mesylate Imatinib attenuates skeletal muscle dystrophy in mdx mice

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 176 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software